NCT01826266
- Conditions
- Anticoagulant Reversal, Reversal of Edoxaban Induced Anticoagulation
- Locations
-
- Duke Clinical Research, Unit 200 Durham, North Carolina, United States
Clinical trial condition
Explore clinical trials studying Anticoagulant Reversal. Study availability and eligibility vary by location and protocol.
NCT01826266